Sort
82,697 grants matching “vaccine development”
Mapping spatiotemporal dynamics during enterovirus infection across cells and tissues
$868,678Raul Andino · University Of California, San Francisco · R01 · FY2022 · AI
Characterization of Persistent COVID-19
$868,661Jonathan Li · Brigham And Women'S Hospital · R01 · FY2023 · AI
ESTABLISHMENT/MAINTENANCE OF BIOMEDICAL RESEARCH COLONY
$868,634University Of Louisiana At Lafayette · U42 · FY2003 · RR
Signal Transduction In B Lymphocytes: Identification Of Key Signaling Molecules
$868,549John H Kehrl · National Institute Of Allergy And Infectious Diseases · ZIA · FY2016 · AI
Development Of Flow Cytometric Technologies For Immune Assays
$868,546Mario Roederer · National Institute Of Allergy And Infectious Diseases · ZIA · FY2011 · AI
Salmonella Group C as part of a multivalent Salmonella vaccine
$868,481Sharon Mei Tennant · University Of Maryland Baltimore · U19 · FY2015 · AI
Elucidating the role of TSR glycosylation in Plasmodium parasites
$868,274Kristian Edward Swearingen · Institute For Systems Biology · R01 · FY2020 · AI
Clinical Evaluation of Novel Adenovirus Prime-Boost HIV-1 Vaccine
$868,211Raphael Dolin · Beth Israel Deaconess Medical Center · U19 · FY2012 · AI
Novel Therapeutics for Neurotropic Alphaviruses
$868,113David J Miller · University Of Michigan At Ann Arbor · R01 · FY2010 · AI
Activated Sugars, Oligosaccharides and Glycans for Antiviral Research
$868,039Leila Aminova · Midwest Bioprocessing Center, Llc · R44 · FY2022 · GM
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS): UNIVERSAL INFLUENZA RESEARCH EFFORTS
$867,817Richard Rothman · Johns Hopkins University · N01 · FY2018 · AI
Project 1 - Profectus Biosciences, Inc.
$867,787John H Eldridge · Henry M. Jackson Fdn For The Adv Mil/Med · U19 · FY2023 · AI
Chlamydial Immunity and Vaccine Development
$867,771Harlan D Caldwell · National Institute Of Allergy And Infectious Diseases · ZIA · FY2012 · AI
The Functional Significance of CTL Escape
$867,756David I Watkins · University Of Wisconsin-Madison · R01 · FY2006 · AI
Scanning the F. tularensis Proteome for Vaccine Antigens
$867,601Philip Louis Felgner · University Of California-Irvine · U01 · FY2006 · AI
Conduct Study P193: Evaluation of Immune Responses after Priming with Newcastle Disease Virus and Boosting with Trimeric gp145 Proteins from Indian and African Clade C HIV-1 Isolates
$867,569Ranajit Pal · Advanced Bioscience Laboratories, Inc. · N01 · FY2015 · AI
Synergistic Nanobodies for Pandemic Preparedness
$867,563Michael P Rout · Rockefeller University · R01 · FY2025 · AI
Posttranscriptional control of gene expression
$867,531Barbara Felber · Division Of Basic Sciences - Nci · ZIA · FY2009 · CA
The functional significance of CTL escape
$867,514David I Watkins · George Washington University · R01 · FY2024 · AI
Core A - Administrative Core
$867,467James W. Leduc · University Of Texas Med Br Galveston · UC7 · FY2021 · AI
Quantitative Immunological Assays to Assess HIV Antibodies and Vaccines
$867,443John Mascola · National Institute Of Allergy And Infectious Diseases · ZIC · FY2021 · AI
HIV Neutralizing Antibodies: Isolation, characterization, and interaction with viral variants
$867,443John Mascola · National Institute Of Allergy And Infectious Diseases · ZIA · FY2021 · AI
Cocktail of Neutralizing MAbs for Smallpox Prevention
$867,437Jeffrey L Nordstrom · Macrogenics, Inc. · U01 · FY2006 · AI
SigH based attenuated, efficacious Mtb vaccines to protect against lethal TB
$867,304Deepak Kaushal · Texas Biomedical Research Institute · R01 · FY2022 · AI
Dengue Reporter Virus Neutralization Assay for Clinical Studies
$867,261Eva Harris · Integral Molecular · R42 · FY2008 · AI